Victory Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-50,555
| Closed | -$44.8K | – | 2741 |
|
|
2022
Q4 | $44.8K | Sell |
50,555
-230,802
| -82% | -$204K | ﹤0.01% | 2463 |
|
|
2022
Q3 | $442K | Buy |
281,357
+162,123
| +136% | +$255K | ﹤0.01% | 2100 |
|
|
2022
Q2 | $240K | Sell |
119,234
-141,128
| -54% | -$284K | ﹤0.01% | 2295 |
|
|
2022
Q1 | $393K | Buy |
260,362
+223,602
| +608% | +$338K | ﹤0.01% | 2215 |
|
|
2021
Q4 | $171K | Buy |
36,760
+2,524
| +7% | +$11.7K | ﹤0.01% | 2511 |
|
|
2021
Q3 | $261K | Sell |
34,236
-16,234
| -32% | -$124K | ﹤0.01% | 2430 |
|
|
2021
Q2 | $489K | Buy |
50,470
+2,398
| +5% | +$23.2K | ﹤0.01% | 2222 |
|
|
2021
Q1 | $398K | Buy |
48,072
+962
| +2% | +$7.97K | ﹤0.01% | 2303 |
|
|
2020
Q4 | $322K | Buy |
47,110
+29,729
| +171% | +$203K | ﹤0.01% | 2262 |
|
|
2020
Q3 | $194K | Buy |
+17,381
| New | +$194K | ﹤0.01% | 2294 |
|